Medical professionals and users of a weight-loss drug have welcomed a recommendation to make it more available and cheaper. Currently, the drugs are discounted only for diabetics, but Wegovy could soon be subsidised for weight loss.
Breakdown
- PBS advisory committee recommends Wegovy for serious weight loss cases 19s
- Subsidy would apply to people with heart problems or grade 2 obesity 40s
- Monthly cost could drop from $380 to under $40 for eligible patients 1m 0s
- Authorities urge proper use and warn of potential mental health impacts 1m 28s
- No direct link found to suicidal thoughts, but caution is advised 1m 43s